Epicardial graft of artificial tissue bioengineered with autologous bone marrow stem cells improves regional perfusion of infarcted myocardium in rats

LI Yan,SONG Bo,LI Xihui,WANG Jin,YANG Yang,XIAO Feng,ZHANG Mingli
DOI: https://doi.org/10.3969/j.issn.1005-8982.2009.05.002
2009-01-01
Abstract:[Objective] To investigate whether the artificial tissue (AT) bioengineered with autologous bone mar-row stem cells (BMSCs) could integrate with the damaged myocardium after it was epicardially grafted as a tissue patch on the infarcted myocardium in rat. [Methods] Myocardial infarction (MI) models were created in 15 Wister rats with selective coronary artery hgature, 3-dimensional AT was constructed by seeding autologous rat BMSCs to collagen matrix. Four weeks later, AT patch was epicardially grafted on the scar area of MI for rats from graft group (n =9), but not for rats from control group (n =6). Serial 99mc-MIBI SPECT myocardial perfusion imaging was per-formed for all animals at 2 weeks before and 2 months after the graft experiment, to monitor the evolution of left ven-tricular (LV) function and myocardial perfusion. The hearts were harvested at the end of study for histological analy-sis, to investigate the fate of BMSCs in bioengineered tissue graft. [Results] Two months later, histological studies showed that BMSCs in bioengineered AT graft survived and completely incorporated with the sear tissue of MI, en-hanced neo-angiogenesis was detected in the AT patch and adjacent infarcted myoeardium, the capillary density per square millimeter and the thickness of the infarcted left ventricular wall in AT graft treated rats was significantly augmented compared with untreated rats, [(246±76) vs (89±21); P =0.01] and [(1.75±0.24) vs (1.35±0.31); P =0.04]. Furthermore, the serial 99mTc-MIBI-SEPCT study revealed an obvious improvement of regional myocardial perfusion in rats from graft group, with a significant reduction of under-perfused MI area and a significant augmentation of 99mTc-sestamibi uptake rate, compared with the control group, [(10%±7.1%) vs (20%±12.9%); P =0.02] and [(65%± 17%) vs (52%±12%); P =0.04]. But the mean value of LVEF had no significant difference between the two groups. [Conclusion] In this study, we confirm that epicardial grafted artificial tissue bioengineered with autologous BMSCs could integrate with infarcted myocardium, introduce neo-angiogenesis and significantly improve the regional my-ocardial peffusion but not the LV function, 2 months after it was implanted in rats.
What problem does this paper attempt to address?